216 related articles for article (PubMed ID: 22495108)
21. Autogenous/reactive obsessions and their relationship with OCD symptoms and schizotypal personality features.
Lee HJ; Telch MJ
J Anxiety Disord; 2005; 19(7):793-805. PubMed ID: 16076425
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder.
Besiroglu L; Uguz F; Saglam M; Agargun MY; Cilli AS
J Affect Disord; 2007 Sep; 102(1-3):73-9. PubMed ID: 17222458
[TBL] [Abstract][Full Text] [Related]
23. The role of comorbid disruptive behavior in the clinical expression of pediatric obsessive-compulsive disorder.
Storch EA; Lewin AB; Geffken GR; Morgan JR; Murphy TK
Behav Res Ther; 2010 Dec; 48(12):1204-10. PubMed ID: 20933220
[TBL] [Abstract][Full Text] [Related]
24. Cognitive therapy for autogenous and reactive obsessions: clinical and cognitive outcomes at post-treatment and 1-year follow-up.
Belloch A; Cabedo E; Carrió C; Larsson C
J Anxiety Disord; 2010 Aug; 24(6):573-80. PubMed ID: 20418053
[TBL] [Abstract][Full Text] [Related]
25. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities?
Storch EA; Lewin AB; Farrell L; Aldea MA; Reid J; Geffken GR; Murphy TK
J Anxiety Disord; 2010 Aug; 24(6):547-52. PubMed ID: 20399603
[TBL] [Abstract][Full Text] [Related]
26. Obsessivecompulsive disorder and traumatic brain injury: behavioral, cognitive, and neuroimaging findings.
Berthier ML; Kulisevsky JJ; Gironell A; López OL
Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):23-31. PubMed ID: 11234906
[TBL] [Abstract][Full Text] [Related]
27. Clinical predictors of health-related quality of life in obsessive-compulsive disorder.
Albert U; Maina G; Bogetto F; Chiarle A; Mataix-Cols D
Compr Psychiatry; 2010; 51(2):193-200. PubMed ID: 20152302
[TBL] [Abstract][Full Text] [Related]
28. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
[TBL] [Abstract][Full Text] [Related]
29. Perceived parental rearing style in obsessive-compulsive disorder: relation to symptom dimensions.
Alonso P; Menchón JM; Mataix-Cols D; Pifarré J; Urretavizcaya M; Crespo JM; Jiménez S; Vallejo G; Vallejo J
Psychiatry Res; 2004 Jul; 127(3):267-78. PubMed ID: 15296826
[TBL] [Abstract][Full Text] [Related]
30. Quality of life in obsessive-compulsive disorder: the different impact of obsessions and compulsions.
Stengler-Wenzke K; Kroll M; Riedel-Heller S; Matschinger H; Angermeyer MC
Psychopathology; 2007; 40(5):282-9. PubMed ID: 17622707
[TBL] [Abstract][Full Text] [Related]
31. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors.
Douglass HM; Moffitt TE; Dar R; McGee R; Silva P
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1424-31. PubMed ID: 8543509
[TBL] [Abstract][Full Text] [Related]
32. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.
Stewart SE; Yen CH; Stack DE; Jenike MA
J Psychiatr Res; 2006 Sep; 40(6):511-9. PubMed ID: 16229857
[TBL] [Abstract][Full Text] [Related]
33. The epidemiology of obsessive--compulsive disorder in Spanish school children.
Canals J; Hernández-Martínez C; Cosi S; Voltas N
J Anxiety Disord; 2012 Oct; 26(7):746-52. PubMed ID: 22858901
[TBL] [Abstract][Full Text] [Related]
34. Markers of vulnerability to obsessive-compulsive disorder in an ultra-high risk sample of patients who developed psychosis.
Fontenelle LF; Lin A; Pantelis C; Wood SJ; Nelson B; Yung AR
Early Interv Psychiatry; 2012 May; 6(2):201-6. PubMed ID: 22510335
[TBL] [Abstract][Full Text] [Related]
35. The psychopathology of parents of children and adolescents with obsessive-compulsive disorder.
Liakopoulou M; Korlou S; Sakellariou K; Kondyli V; Kapsimali E; Sarafidou J; Anagnostopoulos D
Psychopathology; 2010; 43(4):209-15. PubMed ID: 20424501
[TBL] [Abstract][Full Text] [Related]
36. Obsessive-compulsive disorder and romantic functioning.
Abbey RD; Clopton JR; Humphreys JD
J Clin Psychol; 2007 Dec; 63(12):1181-92. PubMed ID: 17972290
[TBL] [Abstract][Full Text] [Related]
37. Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder.
Dougherty DD; Jameson M; Deckersbach T; Loh R; Thompson-Hollands J; Jenike M; Keuthen NJ
Int Clin Psychopharmacol; 2009 Nov; 24(6):306-11. PubMed ID: 19730388
[TBL] [Abstract][Full Text] [Related]
38. The impact of experiential avoidance and obsessive beliefs on obsessive-compulsive symptoms in a severe clinical sample.
Manos RC; Cahill SP; Wetterneck CT; Conelea CA; Ross AR; Riemann BC
J Anxiety Disord; 2010 Oct; 24(7):700-8. PubMed ID: 20627655
[TBL] [Abstract][Full Text] [Related]
39. Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil.
Torresan RC; Ramos-Cerqueira AT; de Mathis MA; Diniz JB; Ferrão YA; Miguel EC; Torres AR
Compr Psychiatry; 2009; 50(1):63-9. PubMed ID: 19059516
[TBL] [Abstract][Full Text] [Related]
40. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
